HealthEquity (HQY) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $8.28B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Scott R. Cutler |
| IPO Date | 2014-07-31 | CAGR | 29.39% |
| Employees | 2,814 | Website | www.healthequity.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.94% | Total Yield | 0.94% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $7.61B | P/E | 23.14 | Forward P/E | 18.18 | PEG | 1.08 |
| P/S | 29.01 | P/B | 19.04 | P/CF | 79.7 | P/FCF | 79.58 |
| Sales | $1.34B | Sales 1Y | 7.58% | Sales 3Y | 48.5% | Sales 5Y | 83.75% |
| EPS | $4.28 | EPS 1Y | 94.28% | EPS 3Y | -2720.22% | EPS 5Y | 4667.86% |
| Sales QoQ | 5.99% | EPS QoQ | 41.38% | Sales QoQ Avg | 1.8% | EPS QoQ Avg | 9.48% |
| Gross Margin | 72.7% | Operating Margin | 25.5% | Profit Margin | 17.25% | ROCE | 10.76% |
| ROA | 7% | ROE | 11% | Altman Z Score | 5.4 | Piotroski Score | 8 |
| Current Ratio | 3.44 | Quick Ratio | 3.44 | Cash Ratio | 1.95 | Op. CF Ratio | 0.72 |
| Debt/Equity | 0.02 | Debt/Assets | 0.01 | Lt Debt/Equity | 0.02 | Lt Debt/Cap. | 0.02 |
| Intrst Cov. | 11.49 | Inventory Turnover | — | Asset Turnover | 0.4 | Receivables Turnover | 10.96 |
| Enterprise Value | $7.61B | P/E Ratio | 23.14 |
| Forward P/E | 18.18 | PEG Ratio | 1.08 |
| P/S Ratio | 29.01 | P/B Ratio | 19.04 |
| P/CF Ratio | 79.7 | P/FCF Ratio | 79.58 |
| EPS | $4.28 | EPS Growth 1Y | 94.28% |
| EPS Growth 3Y | -2720.22% | EPS Growth 5Y | 4667.86% |
| Revenue Growth 1Y | 7.58% | Gross Margin | 0.73% |
| Operating Margin | 0.26% | Profit Margin | 0.17% |
| ROE | 0.11% | ROA | 0.07% |
| ROCE | 0.11% | Current Ratio | 3.44 |
| Quick Ratio | 3.44 | Cash Ratio | 1.95 |
| Debt/Equity | 0.02 | Interest Coverage | 11.49 |
| Altman Z Score | 5.4 | Piotroski Score | 8 |
HealthEquity (HQY) valuation & financials
HealthEquity (HQY) has a market capitalization of $8.28B and trades at a price-to-earnings ratio of 23.1. It operates in the Healthcare sector (Medical - Healthcare Information Services).
HealthEquity's revenue grew +7.6% over the last year.
HealthEquity's next earnings report is scheduled for September 1, 2026 after market close; analysts estimate EPS of $1.19.
HealthEquity (HQY) — frequently asked questions
When does HealthEquity (HQY) report earnings next?
HealthEquity is expected to report earnings on September 1, 2026 after market close. Analysts estimate EPS of $1.19.
What is HealthEquity's market cap?
HealthEquity (HQY) has a market capitalization of $8.28B.
What is HQY's P/E ratio?
HealthEquity trades at a price-to-earnings ratio of 23.1, with trailing twelve-month EPS of $4.28.
How fast is HealthEquity growing?
HealthEquity's revenue grew +7.6% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)